Oncolytics (ONCY) announced the completion of the previously announced change in the jurisdiction of incorporation of Oncolytics from the Province of Alberta in Canada to the State of Nevada in the United States through a series of transactions in which the company first continued its existence from the Province of Alberta in Canada to the Province of British Columbia in Canada on March 17. The company will retain its office in Calgary, while the San Diego office will become the Company’s new headquarters. The domestication was approved by the company’s shareholders at the special meeting of shareholders held on January 15.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ONCY:
- Oncolytics files $250M mixed securities shelf
- Oncolytics Biotech Shifts Corporate Domicile to British Columbia
- Oncolytics Biotech Showcases Pelareorep as Immune-Priming Backbone With New AACR 2026 Data
- Oncolytics Highlights New Pelareorep Data in Cancer Immunotherapy
- Oncolytics to present new data on Pelareorep at AACR 2026